Specific red cell adherence test applied to tumors of ureter and renal pelvis

M. B. Gruber, S. N. Becker, M. M. Warren, M. J. Rambo, C. P. Davis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

Original languageEnglish
Pages (from-to)361-365
Number of pages5
JournalUrology
Volume19
Issue number4
DOIs
StatePublished - 1982

Fingerprint

Kidney Pelvis
Ureter
Urinary Bladder Neoplasms
Neoplasms
Transitional Cell Carcinoma
Urinary Bladder
Neoplasm Metastasis
Survival

ASJC Scopus subject areas

  • Urology

Cite this

Gruber, M. B., Becker, S. N., Warren, M. M., Rambo, M. J., & Davis, C. P. (1982). Specific red cell adherence test applied to tumors of ureter and renal pelvis. Urology, 19(4), 361-365. https://doi.org/10.1016/0090-4295(82)90189-3

Specific red cell adherence test applied to tumors of ureter and renal pelvis. / Gruber, M. B.; Becker, S. N.; Warren, M. M.; Rambo, M. J.; Davis, C. P.

In: Urology, Vol. 19, No. 4, 1982, p. 361-365.

Research output: Contribution to journalArticle

Gruber, MB, Becker, SN, Warren, MM, Rambo, MJ & Davis, CP 1982, 'Specific red cell adherence test applied to tumors of ureter and renal pelvis', Urology, vol. 19, no. 4, pp. 361-365. https://doi.org/10.1016/0090-4295(82)90189-3
Gruber, M. B. ; Becker, S. N. ; Warren, M. M. ; Rambo, M. J. ; Davis, C. P. / Specific red cell adherence test applied to tumors of ureter and renal pelvis. In: Urology. 1982 ; Vol. 19, No. 4. pp. 361-365.
@article{fb49219d9c884e15a392bfb2aa1e52ee,
title = "Specific red cell adherence test applied to tumors of ureter and renal pelvis",
abstract = "The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.",
author = "Gruber, {M. B.} and Becker, {S. N.} and Warren, {M. M.} and Rambo, {M. J.} and Davis, {C. P.}",
year = "1982",
doi = "10.1016/0090-4295(82)90189-3",
language = "English",
volume = "19",
pages = "361--365",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Specific red cell adherence test applied to tumors of ureter and renal pelvis

AU - Gruber, M. B.

AU - Becker, S. N.

AU - Warren, M. M.

AU - Rambo, M. J.

AU - Davis, C. P.

PY - 1982

Y1 - 1982

N2 - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

AB - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

UR - http://www.scopus.com/inward/record.url?scp=0020070243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020070243&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(82)90189-3

DO - 10.1016/0090-4295(82)90189-3

M3 - Article

VL - 19

SP - 361

EP - 365

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -